Skip to main content

Dr. Lu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lu's full profile

Already have an account?

Education & Training

  • Beijing Medical University
    Beijing Medical UniversityClass of 1992

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2019 - 2025
  • NY State Medical License
    NY State Medical License 2019 - 2021
  • LA State Medical License
    LA State Medical License 2019 - 2019

Publications & Presentations

PubMed

Press Mentions

  • InnoCare Announces the Approval of Orelabrutinib in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell Lymphoma
    InnoCare Announces the Approval of Orelabrutinib in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell LymphomaDecember 27th, 2020